MARCo Health offering is now closed and is no longer accepting investments.

INVEST IN MARCO HEALTH TODAY!

Accessible mental healthcare via compassionate robots

MARCo Health is aiming to combat the mental health crisis through our flagship therapeutic robot MARCo - the Mental-Health Assisting Robot Companion. Our goal is to provide individuals struggling with depression, anxiety, stress, and other mental health issues, with 24/7 access to their own private, personalized care through affordable, accessible, and, yes, adorable, mental wellness companions. We have already achieved over $27K in sales, performed early-stage clinical trials, launched a mobile app with thousands of users, and distributed robots across North America, Europe, and Asia. MARCo is patented in the US, patent number 11439346.

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
MARCo Health

$60,614.78 Raised

Reasons to Invest

  • We are one of the very few companies on the market to offer a physical robot for in-person care to our target demographic, focusing on five tracts of mental health interventions.


  • As of 2021, the global investment in mental health technology has climbed to 139% YoY (source). Adding to that, the virtual care industry has grown to 38 times its pre-pandemic levels (source).


  • Our team has a combined 45+ years of experience in robotics and medical devices, and our CEO was the lead engineer for a US Navy robot. Additionally, we have raised $175K from investors, and have been awarded over $30K from a combination of prize funds and grants.




OVERVIEW


Meet MARCo - Your Mental-Health Assisting Robot Companion


MARCo Health believes that everyone should have access to a counselor, advocate, or someone just willing to listen - 24 hours a day, 7 days a week. With the help of MARCo, we are striving to help millions of individuals in need of mental health support. Because to us, no one should feel alone and have to wait to feel better.




MARCo leverages state-of-the-art AI technology to have conversations with users and provide personalized care through five proven forms of therapy: Companionship, Biofeedback, Talk Support, Guided Meditation & Relaxation, and High Alert Outreach.

THE PROBLEM & OUR SOLUTION


MARCo aims to bridge the gap between the lack of mental health professionals and the shortcomings of existing technologies


One-third of young adults struggle with mental health disorders every year, but less than half receive any mental health care (source). Although there are mental health apps out there, they don’t provide that in-person opportunity to connect.

source, source, source

*The above testimonials may not be representative of the opinions of other medical experts or experiences of other customers and is not a guarantee of future performance or success.


By serving as an AI-enabled “someone to talk to” with a physical presence, MARCo simulates the much desired need for an in-person interaction, available 24/7 - at a fraction of the cost of traditional therapy. Utilizing evidence-based therapies including Cognitive Behavioral Therapy, Mindfulness, and Behavioral Activation, MARCo personalizes care with hundreds of different activities that fall under five broader categories.




We generate revenue through both D2C and B2B streams, based on the sales of our robots and subscriptions to our software - which may be bundled with a purchase of our robots.

THE MARKET & OUR TRACTION


Because of COVID-19, the market size for mental health solutions is increasing rapidly


20% of the US population experienced a significant negative impact on their mental health from the pandemic (source). Global investments in the mental health technology sector jumped 139% from $2.3 Billion in 2020 (source), and the virtual care industry has grown to 38 times its pre-pandemic levels (source).



*The above information is based on internal research. 


The growing need for mental health treatment options has fast-tracked the FDA’s authorization of “digital therapeutics” to be brought to market without needing FDA review. Although there are a growing number of virtual chatbot therapists, we have not seen our competition implement long-form conversations - a key customer need - nor do they utilize physical robots.


Not only was the need for a physical companion a frequent request from customer interviews, but an internal study spanning almost two years showed us that a physical companion outperforms an app-only companion across several key business and care metrics.

 

*The above information is based on internal research.


We also believe our initial focus on care for teens and young adults in the US, which has a total addressable market estimated to be $21.2 Billion, differentiates us from our app-based competitors, which we have seen target primarily older adults.


With all this, we truly believe the market needs MARCo. Here’s how we are getting there:


  • Launched a new model of our robot at a consumer friendly price point to launch to our D2C market (source)
  • Scaled internationally with our first international sale to the U.K. and the addition of an exclusive, pan-Asia distributor with the India-based mental health company TransformHappily (source). 
  • Completed the “What If Fellowship” mental health accelerator program
  • Developed clinical research partnership with Hamilton Labs - a youth suicide prevention lab based out of Rutgers University


We generate revenue through both D2C - via online e-commerce - and B2B - via direct sales to private and school-funded counseling practices streams, based on the sales of our robots and subscriptions to our software - which may be bundled with a purchase of our robots.


*Revenue as of September 2022

WHY INVEST


Our vision is a world where no one in a mental health crisis has to wait for care 


In our view, cost, stigma, privacy concerns, mistrust, lack of availability, or any other reason should not prevent someone from getting the mental health care they need. We believe that cost-effective, 24/7 accessible, AI-enabled robot companions are a major step towards a brighter future.


Don’t just take our word for it! Hear it straight from the mouths of those MARCo has helped already:

*The above testimonials may not be representative of the experience of other customers.


*The above testimonials may not be representative of the opinions of other medical experts and is not a guarantee of future performance or success.


With near zero advertising spend, we are already getting more organic orders than we can produce.

*These are historical figures & do not guarantee future performance or success.


An investment at this stage would enable us to push towards more accessible, effective mental healthcare by scaling our production and marketing efforts to meet the high demand we are seeing.


Invest today, and help us on our mission to bring more companionship to the world with MARCo.



Bold (⌘B)

ABOUT

HEADQUARTERS

112 Large Avenue
Hillsdale, NJ 07642
VALUATION

$7.72M

MARCo Health is aiming to combat the mental health crisis through our flagship therapeutic robot MARCo - the Mental-Health Assisting Robot Companion. Our goal is to provide individuals struggling with depression, anxiety, stress, and other mental health issues, with 24/7 access to their own private, personalized care through affordable, accessible, and, yes, adorable, mental wellness companions. We have already achieved over $27K in sales, performed early-stage clinical trials, launched a mobile app with thousands of users, and distributed robots across North America, Europe, and Asia. MARCo is patented in the US, patent number 11439346.

TEAM

Jacob Boyle
Jacob Boyle
CEO, CTO, President, and Director

Jacob is an advanced robotics engineer by trade and a mental health advocate by passion. He has over 7 years experience in engineering robots and medical devices, having started his career as the lead engineer of a startup developing amphibious robots for a US Navy contract, only to leave to repurpose his skills for what he believes is a higher cause. Having spent years caring for friends and family with mental illness, as well as struggling with his own mental health, he takes his work very personally, and believes in treating every customer and client like they are his only priority.

Attiq Amjad

Attiq Amjad

CMO & Director

Attiq is a seasoned business professional with over 15 years of marketing, finance, and general management experience in the medical device and consumer goods industries. Attiq holds an MBA in marketing from Seton Hall University and a B.S. in Finance from Rutgers University.

Dr. Nithin Krishna

Dr. Nithin Krishna

Chief Clinical Officer

A brilliant M&A Healthcare Specialist and Entrepreneur, M.D., and clinical researcher with 15+ years experience in psychiatry and neuroscience

Dr. Nigam Samal

Dr. Nigam Samal

Acting CTO

More than 20 years of experience in Technology and Finance

Tina Mulligan

Tina Mulligan

Customer Success Manager

Accomplished professional counselor with a talent for providing social-emotional advising to adolescents, including at-risk youth and college-bound students.

John Byrne

John Byrne

Healthcare & Business Valuation Specialist/ M&A Advisor/ CPA ABV

More than 25 years of experience in M&A Finance and Accounting

TERMS

MARCo Health
Overview
PRICE PER SHARE
$5
DEADLINE
Dec 30, 2022
VALUATION
$7.72M
AMOUNT RAISED
$60,614.78
Breakdown
MIN INVESTMENT
$250.00
MAX INVESTMENT
$1,235,000.00
MIN NUMBER OF SHARES OFFERED
2,000
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
247,000

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

MARCo Health, Inc

Corporate Address

:

112 Large Avenue, Hillsdale, NJ 07642

Offering Minimum

:

$10,000.00

Offering Maximum

:

$1,235,000.00

Minimum Investment Amount

(per investor)

:

$250.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

1,953

Maximum Number of Shares Offered

:

241,211

Price per Share

:

$5.00

Pre-Money Valuation

:

$7,680,000.00











Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.


Investment Incentives & Bonuses*

Audience-Based:

5% bonus shares for returning investors/supporters

Time-Based:

Friends and Family Early Birds

Invest $250 within the first 72 hours and receive 20% bonus shares

Super Early Bird Bonus

Invest $250 within the first week and receive 15% bonus shares

Early Bird Bonus

Invest $250 within the first two weeks and receive 10% bonus shares

 

Amount-Based:

$500+ | MARCo’s Sponsor

Invest $500+ and get a MARCo swag combo + 2 years free access to the MARCo app + 5% bonus shares

$1,000+ | MARCo’s Friend

Invest $1000+ and get a 15% off the price of any MARCo + 4 years free access to the MARCo app + a MARCo swag combo + 5% bonus shares

$2,500+ | MARCo’s Bestie

Invest $2500+ and get 50% off the price of any MARCo + lifetime access to the MARCo app + a MARCo swag combo + 8% bonus shares

$5,000+ | MARCo’s Hero

Invest $2500+ and get a free MARCo of your choice + 2 x lifetime access to the MARCo app + a MARCo swag combo + 10% bonus shares

$10,000+ | MARCo’s #1 Fan

Invest $10,000+ and get a fully customized MARCo (e.g., your choice of color, design) + MARCo swag combo + 4 x lifetime access to the MARCo app + 15% bonus shares


The 10% StartEngine Owners' Bonus


MARCo Health will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $5.00/ share, you will receive 110 shares Common Stock, meaning you'll own 110 shares for $500. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus 5% returning supporter's bonus in addition to the aforementioned bonus.

*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Salary payments made to one’s self, a friend or relative.

PRESS

Article Image
NJ 101.5

Meet MARCo — NJ students create therapy robot for the mentally ill

Article Image
Clinical Times

Meet MARCo, the robot companion that assists with mental illness

Article Image
Gearadical

We all need friends and MARCo may just be your new bestie

Article Image
USA Today Network

Therapy with a robot? How AI could help those struggling with mental health

Article Image
Techstination

MARCo companion robot to assist with mental health

ALL UPDATES

12.30.22

Campaign Closed | Our Community Joined In! | Insider Investment Notice


Hello all MARCo Friends and Followers!


And that's a wrap! Our first ever equity crowdfunding campaign closed at 11:59 PM last night. The amount of support will make a huge impact on our planned goals for this coming year.


We are grateful to all of our investors and backers in this campaign who believed in us enough to push forward the future of mental healthcare. 


And we were excited to see our community come in and invest in MARCo Health!


Our Insiders have invested a total of $11,550  into the offering to date!


Please refer to the Company’s offering materials for further information and refer to the Company’s Risk Factors.


If you are interested in receiving further updates in our progress moving forward, please stay tuned for updates from our campaign here, and you can also get direct email updates or have all of your future questions answered through our investor email, investors@marcohealthtech.com 


Stay tuned for the next steps in the future of MARCo!


Sincerely,


Jacob Boyle

CEO - MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/

12.30.22

LAST CHANCE - CAMPAIGN CLOSING SOON

Hello MARCo friends and followers,


This is the final campaign update before the close of our campaign at 11:59 PM tonight. 


We have been thrilled by the outpouring of support we've seen in our campaign, and we are grateful to everyone who has invested so far for believing in our mission and joining us in our vision of affordable, accessible, and higher quality mental healthcare for all through MARCo.


But our campaign isn't over yet, and if you haven't gotten in, this is the last chance to invest in the future of mental healthcare during this campaign. 


If you have tried to invest and are having issues, as some of our investors have faced, please comment on our campaign or email us directly at hello@marcohealthtech.com so we can help you resolve any barriers to investment as fast as possible.


For all those following our campaign thus far, we hope you will make the choice to invest in our campaign before it closes tonight and help us close out 2022 on a high note. And for all of those who have already invested, thank you again from all here at MARCo Health Inc.



Sincerely,


Jacob Boyle

CEO - MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/

12.29.22

Campaign Closes Today!


Hello MARCo Friends and Followers!


We are nearing the end of our campaign here on StartEngine - less than 24 hours left to go! Our campaign is set to close today Thursday, December 29th at 11:59 PM EST, and we will not be extending this campaign past that deadline. 


We are looking ahead to next year and all the incredible opportunities we have ahead of us:


- Multiple hospital networks in the pipeline for pilot programs which we believe will launch next year

- Launching clinical and human factor studies with partnering psychiatric and therapy partners

- Our Amazon and eCommerce listings picking up steam and order deliveries across the US with international interest

- Continuing research in MARCo's advanced AI which we believe serves as the basis for future publishable research papers and/or further patents

- Multiple first meetings and grant/contract presubmissions with program officers with the NIH, NSF, and DoD which, based on positive reception from these organizations, means we believe we can submit and earn multiple government grants and contracts next year

- FDA presubmission in process for a first meeting with the FDA estimated to happen in January 2023

- Growing production with suppliers lined up to manufacture higher volume units in quantities of 500-10000 per batch

- A lower cost MARCo we intend to launch in 2023 based on immense (and growing) consumer interest in such a product


To accomplish these goals and many, many more, we are looking for a strong close to our StartEngine campaign. So I humbly ask, if you have not already, please consider investing as this is the last chance you will have for this campaign. And if you cannot at this time, please share our campaign and our mission with anyone you can so we can grow our vision of affordable, accessible, quality mental healthcare for all into a global reality.


We hope that, if you have not already, you will join us in our mission and help us reshape the narrative of our world's global mental health epidemic into one of innovation, hope, and care.


Sincerely,


Jacob Boyle

CEO - MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/

12.27.22

2 Days Remaining - Last Chance to Get In!

Hello MARCo Friends and Followers!


We are nearing the end of our campaign here on StartEngine! As a quick reminder, our campaign is set to close on this Thursday, December 29th at 11:59 PM EST, and we will not be extending this campaign past that deadline. 


While it has been an exhilarating and wonderful experience launching and running our first equity crowdfunding campaign, we have chosen not to extend so we can focus our full team effort onto the incredible opportunities we believe we have ahead for our company:


- Multiple hospital networks in the pipeline for pilot programs which we believe will launch next year

- Launching clinical and human factor studies with partnering psychiatric and therapy partners

- Our Amazon and eCommerce listings picking up steam and order deliveries across the US with international interest

- Continuing research in MARCo's advanced AI which we believe serves as the basis for future publishable research papers and/or further patents

- Multiple first meetings and grant/contract presubmissions with program officers with the NIH, NSF, and DoD which, based on positive reception from these organizations, means we believe we can submit and earn multiple government grants and contracts next year

- FDA presubmission in process for a first meeting with the FDA estimated to happen in January 2023

- Growing production with suppliers lined up to manufacture higher volume units in quantities of 500-10000 per batch

- A lower cost MARCo we intend to launch in 2023 based on immense (and growing) consumer interest in such a product


To accomplish these goals and many, many more, we are looking for a strong close to our StartEngine campaign. So I humbly ask, if you have not already, please consider investing as this is the last chance you will have for this campaign. And if you cannot at this time, please share our campaign and our mission with anyone you can so we can grow our vision of affordable, accessible, quality mental healthcare for all into a global reality.


We hope that, if you have not already, you will join us in our mission and help us reshape the narrative of our world's global mental health epidemic into one of innovation, hope, and care.


Sincerely,


Jacob Boyle

CEO - MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/

12.22.22

Happy Holidays from MARCo Health!


Hello MARCo Friends and Followers!


We at MARCo Health wish you a happy holiday season, whether you formally celebrate Christmas or Hanukkah or you just observe a holiday weekend off from work!


We know this time of year can be stressful - just look at MARCo above - and overwhelming between gifts, travel plans, weather, and either being overwhelmed with family or isolated from loved ones. So remember that, even though it is the season of giving and focusing on others, don't forget to take care of yourself.


 For all of you who have joined in on our campaign so far, we just want to say, your support has been the greatest gift we've received this holiday season. For those who are still contemplating joining in on our campaign, this is the time to do it as our campaign closes on December 29th at 11:59 PM. Every investment goes a long way with us to bring the future of mental healthcare out into the world, so we hope that if you are still debating joining in, you make the decision to join us in our mission and our work.


Have a happy, safe, healthy, and merry holiday from all of us here at MARCo Health Inc!


Best Regards,


Jacob Boyle

CEO - MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/



 

12.19.22

Just Under Two Weeks Left In Campaign!


Hello MARCo friends and followers,


We are coming in on the planned close of our campaign! December 29th, 2022 at 11:59 PM will be the last opportunity to join our movement of revolutionizing mental healthcare and invest in MARCo Health in this crowdfunding offering.


If you have been following us thus far and haven't invested yet, this is the perfect time to join in. As we close out 2022, we are riding a wave of incredible momentum on fantastic opportunities into 2023:


- Multiple hospital networks in the pipeline for pilot programs which we believe will launch next year

- Our Amazon and eCommerce listings picking up steam and order deliveries across the US with international interest

- Multiple first meetings and grant/contract presubmissions with program officers with the NIH, NSF, and DoD which, based on positive reception from these orginizations, means we believe we can submit and earn multiple government grants and contracts next year

- FDA presubmission in process for a first meeting with the FDA estimated to happen in January 2023

- Growing production with suppliers lined up to manufacture higher volume units in quantities of 500-10000 per batch

- A lower cost MARCo we intend to launch in 2023 based on consumer interest in such a product


But for these initiatives and many more we have lined up, we need the backing of our supporters. Please consider investing in our campaign to help us make our vision of affordable, accessible, and high quality mental healthcare for all possible. And if you cannot invest, share, spread the word, and forward our campaign to others you think believe in our mission and want to join in our successes.


Sincerely,


Jacob Boyle

CEO - MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/


12.12.22

CEO Featured In Brainz 500


Hi MARCo friends and followers,


We got some exciting news this morning! Our CEO has been featured in the Brainz Magazine Brainz 500 list! You can check out the official honoree page here:


https://www.brainzmagazine.com/brainz-500-global-2022/jacob-boyle


The Brainz 500 honorees represent 500 of the best companies and influential leaders in the business of helping others on a global scale. The list features CEOs and thought leaders across the health, wellness, psychology, relationship, and entrepreneurial achievement spheres. Some other notable names on this list include Marc Randolph Co-founder and first CEO of Netflix, Marissa Peer World-renowned therapist and best-selling author, and  Vishen Lakhiani Founder & CEO, Mindvalley, although you can see the whole list here.


We are humbled to receive this recognition for our work, and we take it as yet another reminder that the work we are doing is worth pursuing. 


But no matter how hard we pursue our goals of affordable, accessible, quality mental healthcare for all, we still need the backing of MARCo supporters to accomplish these goals, so we are humbly asking that you join us on our journey. Even if you can't invest, spread the word, share our story, and help us close out our campaign, and this year, with an enormous showing of support. 


Sincerely,

The MARCo Health Team

MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/

12.09.22

3 Weeks Until Campaign Closes!

Hello MARCo Friends and Followers! 


Happy December everyone! We are closing in on the end of our campaign - December 30th is the last day of our campaign. We are thrilled with the outpouring of support we've received so far, and we are also excited to close out this campaign strong!


But we need your help! If you have been following us and waiting to invest, this is the perfect time to get in on the future of mental healthcare. We are looking for a strong push at the end of this campaign to close out 2022 on a high note and push straight into the opportunities we have planned for the very start of 2023. 


In Q1 of 2023, we intend to file our presubmission for FDA clearance with the FDA, apply to multiple SBIR grants with the NIH and NSF to further MARCo research, scale MARCo production to hundreds of units, and launch pilot programs at a number of hospitals and health networks that are currently in our funnel.


But we need the backing of MARCo supporters to accomplish these goals, so we are humbly asking that you join us on our journey. Even if you can't invest, spread the word, share our story, and help us close out our campaign, and this year, with an enormous showing of support. 


Sincerely,


Jacob Boyle

CEO - MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/


11.23.22

MARCo Featured in Brainz Magazine!

Hello MARCo Friends and Followers!


We've got some exciting news! MARCo just got featured in Brainz magazine - a leading global publication on psychology, neuroscience, and the entrepreneurs + tech that bring these fields into the future. You can read the article here:


https://www.brainzmagazine.com/post/marco-health-brings-its-premiere-mental-health-robots-to-the-crowd


Not only that, but Brainz Magazine has told us that we were nominated to the Brainz 500 for induction into their December cohort of winners - think Forbes 500 but specifically for mental health tech companies. So everyone keep their fingers crossed (and MARCo will keep its mittens crossed) that we'll be selected next month for this prestigious award!


Our team members have been picked up on a number of podcasts and interviews recently as well, so be sure to follow this campaign if you haven't already to see the latest and greatest of MARCo making headlines!


And to all our backers, I want to say again, thank you for joining our mission. If you want to see your impact and investment go even further, please make sure to share our company and campaign with anyone and everyone you may know who may be interested. And even if you are just following for now, a share can go a long way, so please do consider sharing and spreading the word.


Thank you all and stay tuned for the next latest and greatest update in MARCo's journey!


Sincerely,


Jacob Boyle

CEO - MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/


11.18.22

MARCo Takes First Step Towards FDA Clearance


Hello all MARCo friends and followers,


We are very excited to share that we are taking the first steps towards our ultimate goal of an FDA cleared MARCo product. We recently engaged with an FDA consultancy firm - FDA Consultants - with over 30 years of experience in successfully navigating companies through FDA medical device applications from start to finish. Our first project with them will be completing an FDA Q-Submission, which we believe we can submit and have our first formal meeting with an FDA panel of experts by the end of this calendar year.


The results of that Q-Submission will cement our path forward to bringing MARCo to regulatory clearance in the U.S. We believe the results of the meeting and feedback from the FDA will enable us to identify whether MARCo has enough of a predicate to go for a traditional classification, if it is so cutting edge that it would go through a DeNovo pathway and forge its own classification, or if it can earn breakthrough device status - a status which would open up additional government funds for our company. Given previous research on existing classifications, we currently believe we have a path to breakthrough device status. 


Based on previous work the FDA Consultants have done, as well, we believe that we can achieve FDA clearance in 12-18 months from now. This is based on previous successes of the consultancy firm as well as industry standards.


Why is FDA clearance needed if we're on the market?


While we will continue to sell our wellness & support version of MARCo, we believe FDA clearance will be key to unlocking MARCo's ultimate growth potential. First, FDA clearance is a required step to get MARCo covered by insurance and other medical payment plans. Second, it would enable us to bring MARCo to higher risk customers and larger institutions whose focus is on high risk individuals - a core part of our mission. Combined, we believe that the increase in target market size and insurance coverage abilities will enable us to grow sales and build a more legitimate brand.


We will keep you all posted as we continue on this FDA clearance journey! 


And to all our backers, I want to say again, thank you for joining our mission. If you want to see your impact and investment go even further, please make sure to share our company and campaign with anyone and everyone you may know who may be interested. And even if you are just following for now, a share can go a long way, so please do consider sharing and spreading the word.


Thank you all and stay tuned for the next latest and greatest update in MARCo's journey!


Sincerely,


Jacob Boyle

CEO - MARCo Health Inc.

Website: https://www.marcohealthtech.com

Facebook: https://www.facebook.com/marcohealthtech

Instagram: @marcotherobot

TikTok: @marcotherobot

LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/

Owners bonus
Stack Owner's Bonus & Rewards!

Members get an extra 10% shares in addition to rewards below!

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into MARCo Health.

$250.00

StartEngine Owner’s Bonus

This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$500.00

$500+ | MARCo’s Sponsor

Invest $500+ and get a MARCo swag combo + 2 years free access to the MARCo app + 5% bonus shares

$1,000.00

$1,000+ | MARCo’s Friend

Invest $1000+ and get a 15% off the price of any MARCo + 4 years free access to the MARCo app + a MARCo swag combo + 5% bonus shares

$2,500.00

$2,500+ | MARCo’s Bestie

Invest $2500+ and get 50% off the price of any MARCo + lifetime access to the MARCo app + a MARCo swag combo + 8% bonus shares

$5,000.00

$5,000+ | MARCo’s Hero

Invest $5000+ and get a free MARCo of your choice + 2 x lifetime access to the MARCo app + a MARCo swag combo + 10% bonus shares

$5,000.00

$5,000+ | MARCo’s Hero

Invest $5,000+ and get a free MARCo of your choice + 2 x lifetime access to the MARCo app + a MARCo swag combo + 10% bonus shares

$10,000.00

$10,000+ | MARCo’s 1 Fan

Invest $10,000+ and get a fully customized MARCo (e.g., your choice of color, design) + MARCo swag combo + 4 x lifetime access to the MARCo app + 15% bonus shares

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

SECURE

Your info is your info. We take pride in keeping it that way!

DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

RAISED
$60,614.78
INVESTORS
27
MIN INVEST
$250.00
VALUATION
$7.72M

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Blog

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.